Aire Advisors’s Pulse Biosciences PLSE Stock Holding History

Aire Advisors’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,413	Closed	-$198K	–	173
2025 Q4	$198K	Buy	+14,413	New	+$225K	0.04%	148

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Aire Advisors's PLSE Position: Q1 2026 in Review

Aire Advisors sold out of Pulse Biosciences (PLSE) in Q1 2026, closing a stake of 14,413 shares — an estimated $198K sold.

Aire Advisors first reported a position in PLSE in Q4 2025 and held it in 1 quarter. The position peaked at $198K in Q4 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

Aire Advisors reported no remaining Pulse Biosciences position as of Q1 2026 after selling out during the quarter.
Aire Advisors sold 14,413 Pulse Biosciences shares in Q1 2026, an estimated $198K.
Aire Advisors first reported a position in Pulse Biosciences in Q4 2025 and held it in 1 quarter.
Aire Advisors's Pulse Biosciences position peaked at $198K in Q4 2025.
96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Aire Advisors's 13F filing for Q1 2026, filed 6 May 2026.